Publication date: October 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 10 Author(s): Marina Jiménez-Martínez, Tineke A. de Jong, Miranda Houtman, Johanna F. Semmelink, Noam Zelcer, Marleen G.H. van de Sande, Wendy Dankers, Lisa G.M. van Baarsen
Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726002815?dgcid=rss_sd_all
Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S0003496726002815?dgcid=rss_sd_all
“Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals.” Annals of the Rheumatic Diseases.
@article{article107113,
title = {Enhanced lipolysis in synovial fibroblasts mark early pathogenic changes in RA-risk individuals},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726002815?dgcid=rss_sd_all}
}
Objective Black patients with systemic sclerosis (scleroderma) have more severe disease than White patients. We investigated whether racial differences in therapeutic responses to mycophenolate mofetil (MMF) could explain this...